Evidence-Based modification of intratympanic gentamicin injections in patients with intractable vertigo

Otology and Neurotology

Volumn 31, Issue 4, 2010, Pages 642-648

  Zhai, Feng ^a   Liu, Jian Ping ^a   Dai, Chun Fu ^a   Wang, Qi ^b   Steyger, Peter S ^b  

^a FUDAN UNIVERSITY   (China)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Gentamicin; Intratympanic injection; M ni re's disease; Vertigo

Indexed keywords

ANTIINFECTIVE AGENT; GENTAMICIN;

ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; BIOAVAILABILITY; CONFOCAL MICROSCOPY; GUINEA PIG; HUMAN; INJECTION; MENIERE DISEASE; MIDDLE EAR; TREATMENT OUTCOME; VERTIGO;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-BACTERIAL AGENTS; BIOLOGICAL AVAILABILITY; EAR, MIDDLE; GENTAMICINS; GUINEA PIGS; HUMANS; INJECTIONS; MENIERE DISEASE; MICROSCOPY, CONFOCAL; TREATMENT OUTCOME; VERTIGO;

EID: 77953083395     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0b013e3181dbb30e     Document Type: Article

References (36)

1. Yazdi AK, Rutka J. Results of labyrinthectomy in the treatment of Ménière's disease and delayed endolymphatic hydrops. J Otolaryngol 1996;25:26-31.
2. Gacek RR, Gacek MR. Comparisonof labyrinthectomy and vestibular neurectomyin the control of vertigo. Laryngoscope 1996;106:225-30.
3. Cohen-Kerem R, Kisilevsky V, Einarson TR, Kozer E, Koren G, Rutka JA. Intratympanic gentamicin for Ménière's disease: a metaanalysis. Laryngoscope 2004;114:2085-91.
4. Stefano AD, Dispenza F, Donato GD, Caruso A, Taibah A, Sanna M. Intratympanic gentamicin: a 1-day protocol treatment for unilateral Ménière's disease. Am J Otolaryngol Head Neck Med Surg 2007;28:289-93.
5. Sala T. Transtympanic gentamicin in the treatment of Méniè re's disease. Auris Nasus Larynx 1997;24:239-46.
6. Bauer PW, MacDonald CB, Cox LC. Intratympanic gentamicin therapy for vertigo in nonserviceable ears. Am J Otolaryngol 2001;22:111-5.
7. Casani A, Nuti D, Franceschini SS, Gaudini E, Dallan I. Transtympanic gentamicin and fibrin tissue adhesive for treatment of unilateral Ménière's disease: effects on vestibular function. Otolaryngol Head Neck Surg 2005;133:929-35.
8. Driscoll CLW, Kasperbauer JL, Facer GW, et al. Low-dose intratympanic gentamicin and the treatment of Ménière's disease: preliminary results. Laryngoscope 1997;107:83-9.
9. Rauch SD, Oas JG. Intratympanic gentamicin for treatment of intractable Ménière's disease: a preliminary report. Laryngoscope 1997;107:49-55.
10. Wu IC, Minor LB. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease. Laryngoscope 2003;113:815-20.
11. Kimura RS, Lee KS, Nye CL, Trehey JA. Effects of systemic and lateral semicircular canal administration of aminoglycosides on normal and hydropic inner ears. Acta Otolaryngol 1991;111:1021-30.
12. Okuda T, Sugahara K, Shimogori H, Yamashita H. Inner ear changes with intracochlear gentamicin administration in guinea pigs. Laryngoscope 2004;114:694-7. (Pubitemid 38548782)
13. Harner SG, Driscoll CL, Facer GW, Beatty CW, McDonald TJ. Long-term follow-up of transtympanic gentamicin for Ménière's syndrome. Otol Neurotol 2001;22:210-14.
14. Chia SH, Gamst AC, Anderson JP, Harris JP. Intratympanic gentamicin therapy for Ménière's disease: a meta-analysis. Otol Neurotol 2004;25:544-52.
15. Steyger PS, Peters SL, Rehling J, Hordichok A, Dai CF. Uptake of gentamicin by bullfrog saccular hair cells in vitro. JARO 2003;4:565-78.
16. Lyford-Pike S, Vogelheim C, Chu E, Santina CCD, Carey JP. Gentamicin is primarily localized in vestibular type I hair cells after intratympanic administration. JARO 2007;8:497-508.
17. Roehm P, Hoffer M, Balaban CD. Gentamicin uptake in the chinchilla inner ear. Hearing Research 2007;230:43-52.
18. Imamura S, Adams JC. Distribution of gentamicin in the guinea pig inner ear after local or systemic application. JARO 2003;4:176-95.
19. Hibi T, Suzuki T, Nakashima T. Perilymphatic concentration of gentamicin administered intratympanically in guinea pigs. Acta Otolaryngol 2001;121:336-41.
20. Bunting EC, Park DL, Durham D, Girod DA. Gentamicin pharmacokinetics in the chicken inner ear. JARO 2004;5:144-52.
21. Wang Q, Steyger PS. Trafficking of systemic fluorescent gentamicin into the cochlea and hair cells. J Assoc Res Otolaryngol 2009;10:205-19.
22. Kimura RS, Lee KS, Nye CL, Trehey JA. Effects of systemic and lateral semicircular canal administration of aminoglycosides on normal and hydropic inner ears. Acta Otolaryngol 1991;111:1021-30.
23. Plontke SK, Mynatt R, Gill RM, Borgmann S, Salt AN. Concentration gradient along the scala tympani after local application of gentamicin to the round window membrane. Laryngoscope 2007;117:1191-8.
24. Meyer J, Mack AL, Gummer AW. Pronounced infracuticular endocytosis in mammalian outer hair cells. Hear Res 2001;161:10-22.
25. Hashino E, Shero M. Endocytosis of aminoglycoside antibiotics in sensory hair cells. Brain Res 1995;704:135-40.
26. Mangiardi D, Cotanche DA. Mechanisms of aminoglycoside induced hair cell death. The Volta Review 2005;105:357-70.
27. Hashino E, Shero M, Salvi RJ. Lysosomal targeting and accumulation of aminoglycoside antibiotics in sensory hair cells. Brain Res 1997;777:75-85.
28. Hiel H, Bennani H, Erre J, Aurousseau C, Aran J. Kinetics of gentamicin in cochlear hair cells after chronic treatment. Acta Otolaryngol 1992a; 112:272-7.
29. Dulon D, Hiel H, Aurousseau C, Erre JP, Aran JM. Pharmacokinetics of gentamicin in the sensory hair cells of the organ of Corti: rapid uptake and long term persistence. C R Acad Sci III 1993;316:682-7.
30. Committee on Hearing and Equilibrium. Guidelines for the diagnosis and evaluation of Ménière's disease. Otolaryngol Head Neck Sur 1995;113:181-5.
31. Atlas JT, Parnes LS. Intratympanic gentamicin titration therapy for intractable Ménière's disease. Am J Otolaryngol 1999;20:357-63.
32. Minor LB. Intratympanic gentamicin for control of vertigo in Ménière's disease: vestibular signs that specify completion of therapy. Am J Otol 1999;20:209-19.
33. Reid CB, Eisenberg R, Halmagyi GM, Fagan PA. The outcome of vestibular nerve section for intractable vertigo: the patient's point of view. Laryngoscope 1996;106:1553-6.
34. Kaplan DM, Nedzelski JM, Chen JM, Shipp DB. Intratympanic gentamicin for the treatment of unilateral Ménière's disease. Laryngoscope 2000;2000:1298-305.
35. Odkvist LM, Bergenius J, Möller C. When and how to use gentamicin in the treatment of Ménière's disease. Acta Otolaryngol Suppl 1997;526:54-7.
36. Hoffer ME, Allen K, Kopke RD, Weisskopf P, Gottshall K, Wester D. Transtympanic versus sustained-release administration of gentamicin: kinetics, morphology, and function. Laryngoscope 2001;111:1343-5.